BSX Stock Analysis: Buy, Sell, or Hold?
BSX - Boston Scientific Corp.
$50.37
1.00 (2.03%)
â˛
5d:
-2.82%
30d:
+15.58%
90d:
-11.86%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 20, 2026 at $49.37 · last confirmed Aug 20, 2026
Strength: 7.0/10
Get Alerted When BSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BSX is fairly priced but lacks strong directional signals. At -6.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BSX is fairly priced but lacks strong directional signals. At -6.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$75.90
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$47.13
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BSX is currently trading at $50.37, which is considered slightly high relative to its 30-day fair value range of $44.20 to $50.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.7) compared to its historical average (18.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.8% over the next few years. This pessimistic expectation contrasts with the company's recent 15.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is currently testing key support at $49.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BSX scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is currently testing key support at $49.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BSX scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$44.20 -
$50.54
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.9%
Protect Your Profits
Holding BSX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.5% below Wall St target ($62.69)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$44.20 -
$50.54
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$49.01
Resistance Level
$52.99
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.65
Wall Street Target
$62.69
(+24.5%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
15.1%
Profit Margin
17.5%
Valuation Discount vs History
-6.8% cheaper
PE vs Historical
14.7 vs 18.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.8%
(market-implied from PE analysis)
1-Year Target
$46.94
(-7%)
2-Year Target
$43.75
(-13%)
3-Year Target
$40.78
(-19%)
3-Yr Target (if PE normalizes)
(PE: 15â18)
$50.38
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 4.1%)
$77.81
(+55%)
Base:
(SPY PE: 14.6, Growth: 4.1%)
$56.80
(+13%)
Bear:
(PE: 12.5, Growth: 4.1%)
$48.28
(-4%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 21.01 | Current EPS (TTM): $2.35
Bull Case
$79.46
(+58%)
Analyst growth 46.3%, PE expands to 23.1
Base Case
$72.24
(+43%)
Market implied 46.3%, PE stable at 21.0
Bear Case
$33.57
(-33%)
Severe decline -20.0%, PE contracts to 17.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.6 to 18.1
Stabilization Target:
$62.24
(+23.6%)
PE Expansion Potential:
+23.6%
Share & Embed Analysis
Last updated: August 22, 2026 1:17 PM ET
Data refreshes hourly during market hours. Next update: 2:17 PM
Data refreshes hourly during market hours. Next update: 2:17 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BSX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
SELL
2026-02-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
Advanced BSX Option Strategies
Professional options setups generated by AI based on today's BSX price and gamma walls.
